These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. The 2005 International Symposium on Advances in Targeted Therapies: what have we learned in the 2000s and where are we going? Maini RN Ann Rheum Dis; 2005 Nov; 64 Suppl 4():iv106-8. PubMed ID: 16239377 [TBL] [Abstract][Full Text] [Related]
48. TPMT testing in rheumatology: any better than routine monitoring? Payne K; Newman W; Fargher E; Tricker K; Bruce IN; Ollier WE Rheumatology (Oxford); 2007 May; 46(5):727-9. PubMed ID: 17255139 [No Abstract] [Full Text] [Related]
49. Practical Pearls About Current Rheumatic Medications. Ward IM; Knott A Prim Care; 2018 Jun; 45(2):193-212. PubMed ID: 29759120 [TBL] [Abstract][Full Text] [Related]
50. The use of methotrexate in childhood rheumatic diseases. Wallace CA Arthritis Rheum; 1998 Mar; 41(3):381-91. PubMed ID: 9506564 [No Abstract] [Full Text] [Related]
51. Pharmacogenetics and rheumatology: Molecular mechanisms contributing to variability in drug response. Asanuma Y; Xie HG; Stein CM Arthritis Rheum; 2005 May; 52(5):1349-59. PubMed ID: 15880820 [No Abstract] [Full Text] [Related]
52. 'Compliance' is futile but is 'concordance' between rheumatology patients and health professionals attainable? Treharne GJ; Lyons AC; Hale ED; Douglas KM; Kitas GD Rheumatology (Oxford); 2006 Jan; 45(1):1-5. PubMed ID: 16361701 [No Abstract] [Full Text] [Related]
53. Observations from the OMERACT Drug Safety Summit, May 2008. Simon LS; Strand CV; Boers M; Brooks PM; Henry D; Tugwell PS J Rheumatol; 2009 Sep; 36(9):2110-3. PubMed ID: 19738222 [TBL] [Abstract][Full Text] [Related]
54. [Tolerance of anti-TNF alpha: the experience acquired in inflammatory rheumatic disease]. Mariette X Ann Dermatol Venereol; 2006 May; 133(5 Pt 2):1S8-12. PubMed ID: 16967603 [No Abstract] [Full Text] [Related]
55. Refining drug safety in rheumatology. Cush JJ; Dao KH Rheum Dis Clin North Am; 2012 Nov; 38(4):xi-xiv. PubMed ID: 23137585 [TBL] [Abstract][Full Text] [Related]
56. Rheumatology nursing. Evolution of the role and functions of a subspecialty. Pigg JS Arthritis Care Res; 1990 Sep; 3(3):109-15. PubMed ID: 2285749 [TBL] [Abstract][Full Text] [Related]
57. Progress towards an OMERACT-ILAR guideline for economic evaluations in rheumatology. Gabriel SE; Tugwell P; Drummond M Ann Rheum Dis; 2002 Apr; 61(4):370-3. PubMed ID: 11874847 [TBL] [Abstract][Full Text] [Related]
58. Optimisation of assessment for rheumatic diseases in clinical trials, observational studies and routine clinical care. Pincus T; Braun J; Kavanaugh A; Smolen JS Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-1. PubMed ID: 25365080 [No Abstract] [Full Text] [Related]
59. [Individual and interdisciplinary treatment of rheumatic diseases in pregnancy]. Bolz M Dtsch Med Wochenschr; 2008 Nov; 133(46):2415. PubMed ID: 18988135 [No Abstract] [Full Text] [Related]
60. Uptake of influenza vaccination in rheumatology patients. Saravana S Rheumatology (Oxford); 2004 Aug; 43(8):1055. PubMed ID: 15258293 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]